Aliphatic Polyester-Based Materials for Enhanced Cancer Immunotherapy

Macromol Biosci. 2021 Jul;21(7):e2100087. doi: 10.1002/mabi.202100087. Epub 2021 Apr 28.

Abstract

Poly(lactic acid) (PLA) and its copolymer, poly(lactic-co-glycolic acid) (PLGA), based aliphatic polyesters have been extensively used for biomedical applications, such as drug delivery system and tissue engineering, thanks to their biodegradability, benign toxicity, renewability, and adjustable mechanical properties. A rapidly growing field of cancer research, the development of therapeutic cancer vaccines or treatment modalities is aimed to deliver immunomodulatory signals that control the quality of immune responses against tumors. Herein, the progress and applications of PLA and PLGA are reviewed in delivering immunotherapeutics to treat cancers.

Keywords: cancer immunotherapy; cancer vaccine; drug delivery; immune checkpoint blockade; poly(lactic-co-glycolic acid); polyester.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cancer Vaccines*
  • Drug Delivery Systems
  • Immunotherapy
  • Neoplasms* / therapy
  • Polyesters
  • Polymers / therapeutic use

Substances

  • Cancer Vaccines
  • Polyesters
  • Polymers